Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy

BACKGROUND-: Data exist that demonstrate isoflavones' potent antiproliferative effects on prostate cancer cells. We evaluated the efficacy of isoflavone in patients with PSA recurrent prostate cancer after prior therapy. We postulated that isoflavone therapy would slow the rate of rise of serum...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Pendleton, John M, Tan, Winston W, Anai, Satoshi, Chang, Myron, Hou, Wei, Shiverick, Kathleen T, Rosser, Charles J
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2008
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2394534/
https://ncbi.nlm.nih.gov/pubmed/18471323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-8-132
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars